期刊文献+

中药鼻腔给药技术研究进展

Research progress on nasal administration technologies of traditional Chinese medicine
下载PDF
导出
摘要 【目的】中药鼻腔给药技术具有给药方便、靶向性好、生物利用度高、吸收速度快等优势,该剂型成为中药新型给药制剂研发的热点。对近年来中药鼻腔给药技术的相关文献进行整理,旨在为中药鼻腔给药技术的研究发展提供参考。【研究现状】综述中药滴鼻剂、气雾剂、粉雾剂、凝胶剂、膜剂、微乳剂等几个中药鼻腔给药常用剂型的特点及应用,总结中药药理及药代动力学、质量控制、刺激性研究、装置开发等方面的研究进展。【结论与展望】中药鼻腔给药技术已经广泛应用到临床且效果值得肯定,但目前中药鼻腔给药技术仍然存在处方优化、技术受限、缺少有效质量控制方法等问题,今后的研究应在处方优化、装置开发和辅料开发等方面,不断完善中药鼻腔给药的质量控制体系。 Significance Nasal drug delivery technology of traditional Chinese medicine(TCM)is a new administration method where Chinese herbal medicines are prepared and placed in the nasal cavity in a certain dosage form and absorbed by the nasal mucosa to exert local or systemic therapeutic effects.Compared to traditional dosage forms such as injections or oral preparations,nasal drug delivery has the advantages of convenient administration,good targeting,high safety,and fast absorption.It is particularly effective for the treatment of upper respiratory tract infection and other diseases.Therefore,this technology has been widely used in recent years and has become a hot spot in the research and development of new TCM drug delivery systems.Progress Various nasal dosage forms of TCM have been developed,including nasal drops,lotions,emulsions,aerosols,sprays,powder sprays,sniffing agents,gels,and films.Among them,nasal drops are easy to prepare and cost-effective,but have some shortcomings such as inaccurate dosage,uneven distribution,and easy loss in the nasal cavity.Powder sprays,which do not require propellants and pressure devices,are environmentally friendly,more stable,and have sustained and controlled release.However,they may not deliver the drug effectively to nasal cavity due to varying particle sizes.Aerosols and sprays distribute evenly,are not easily lost,and can achieve bioavailability of 70%~80%.However,they require special injection valve systems and specific containers,which are costly to manufacture and contain propellants that may cause mucosal irritation.Gels,films,and microemulsions can extend the residence time of the drug in the nasal mucosa,improving bioavailability and reducing the administration frequency while increasing drug loading.However,their preparation processes are complex,and their efficacy is unstable.The paper reviews the characteristics and applications of TCM nasal dosage forms,including nasal drops,aerosols,powders,gels,film agents,microemulsions,introduces the theoretical basis,and summarizes the research progress in pharmacology,pharmacokinetics,quality control,irritant studies,and device development.Conclusions and Prospects Current TCM nasal drug delivery systems face several challenges:1)Most of the TCM nasal administrations involve strong odor and irritating drugs,which can easily cause nasal allergies or injuries.2)TCM nasal administration mainly focuses on symptom relief,causing diseases prone to relapse.3)The preparation of TCM nasal formulations is simple,with low drug utilization,typically involving direct grinding or decoction.4)Absorption enhancers used in clinical studies are often toxic,and may cause greater irritation to the nasal mucosa.They have a greater impact on nasal cilia function and lead to adverse reactions in patients.To address these issues,specific drug and prescription analysis are needed.It is necessary to optimize prescription drugs,select appropriate excipients such as absorption enhancers,and develop effective drug delivery devices.Future studies should emphasize both basic and applied research in TCM nasal drug delivery systems,focusing on pharmacology and pharmacokinetics,quality control methods,and toxic side effects.In addition,new technologies,processes,and methods should be developed to leverage the potential of TCM nasal drug delivery technologies.
作者 李文龙 冯佳豪 董文亮 沙鑫 陈伟 周桂芳 LI Wenlong;FENG Jiahao;DONG Wenliang;SHA Xin;CHEN Wei;ZHOU Guifang(College of Pharmaceutical Engineering of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Haihe Laboratory of Modern Chinese Medicine,Tianjin 301617,China;Shanghai Zhenrentang Pharmaceutical Co.,Ltd.,Shanghai 201814,China)
出处 《中国粉体技术》 CAS CSCD 2024年第5期81-90,共10页 China Powder Science and Technology
基金 国家重点研发计划项目,编号:2023YFC3504502 上海市2022年度“科技创新行动计划”生物医药科技支撑专项项目,编号:22S21904600。
关键词 中药 鼻腔给药技术 质量控制 traditional Chinese medicine nasal administration technology quality control
  • 相关文献

参考文献14

二级参考文献105

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部